In the landmark, large clinical studies of both semaglutide and tirzepatide for weight loss, participants took 1.7 or 2.4 mg of semaglutide and 5, 10, or 15 mg of tirzepatide
Wegovy, a medication that contains semaglutide, the same main ingredient as Ozempic, and Zepbound, a medication that contains tirzepatide, the same main ingredient as Mounjaro, are both FDA-approved for weight loss
These steps also help limit nausea, reflux, and constipation during dose escalation
Combination products like cagrilintide and semaglutide introduce additional stability considerations
Learn why professional medical supervision is the critical component for turning a clinical prescription into a sustainable, long-term lifestyle transformation